Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

Doctor recommended no action for U.S.' Pelosi after coronavirus contact

Published 03/30/2020, 05:41 PM
Updated 03/30/2020, 06:25 PM
© Reuters. House Speaker Pelosi holds coronavirus aid bill signing ceremony at the U.S. Capitol in Washington

WASHINGTON (Reuters) - The U.S. Congress' attending physician recommended U.S. House Speaker Nancy Pelosi take no particular action after she was in contact with Representative Nydia Velazquez, who has been diagnosed with coronavirus infection, Pelosi's spokesman Drew Hammill said on Monday.

The physician found Pelosi's contact with Velazquez to have been of "low risk," Hammill said. Velazquez, a Democrat from New York, announced in a statement earlier on Monday that she had been diagnosed with a presumed case of coronavirus, although she had not been tested, after developing symptoms of the ailment on Sunday. Velazquez was in the U.S. Capitol on Friday and attended a ceremony at which Pelosi signed a $2.2 trillion coronavirus response plan.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.